Skip Page Header

Home > EMCDDA technical report on the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene),

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2020) EMCDDA technical report on the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene),. Lisbon: EMCDDA. 40 p.

[img]
Preview
PDF (EMCDDA technical report on isotonitazene)
819kB

URL: https://www.emcdda.europa.eu/publications/technica...

The purpose of this technical report is to provide an analysis of the available information on N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (commonly known as isotonitazene), an opioid analgesic that has recently emerged on the drug market in Europe, to support a risk assessment of the substance that has been requested by the European Commission in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended).

[Explanatory note: In the interests of public health protection the EMCDDA is releasing this report before formal copy editing and page layout in the EMCDDA house style. The final report will be available in due course.]


Item Type
Evidence resource
Publication Type
Report
Drug Type
Opioid, New psychoactive substance
Intervention Type
AOD disorder harm reduction
Source
Date
4 June 2020
Pages
40 p.
Publisher
EMCDDA
Corporate Creators
European Monitoring Centre for Drugs and Drug Addiction
Place of Publication
Lisbon
EndNote

Repository Staff Only: item control page